Shielding of Hepatitis B Virus-Like Nanoparticle with Poly(2-Ethyl-2-Oxazoline)

Virus-like nanoparticles (VLNPs) have been studied extensively as nanocarriers for targeted drug delivery to cancer cells. However, VLNPs have intrinsic drawbacks, in particular, potential antigenicity and immunogenicity, which hamper their clinical applications. Thus, they can be eliminated easily...

Descripción completa

Detalles Bibliográficos
Autores principales: Fam, See Yee, Chee, Chin Fei, Yong, Chean Yeah, Ho, Kok Lian, Mariatulqabtiah, Abdul Razak, Lau, Han Yih, Tan, Wen Siang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801929/
https://www.ncbi.nlm.nih.gov/pubmed/31623310
http://dx.doi.org/10.3390/ijms20194903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801929/
https://www.ncbi.nlm.nih.gov/pubmed/31623310
http://dx.doi.org/10.3390/ijms20194903

Ejemplares similares